These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26070802)

  • 21. [Ascorbic acid: a first generation drug for Charcot-Marie-Tooth disease].
    Fontès M
    Med Sci (Paris); 2004 Oct; 20(10):843-4. PubMed ID: 15461953
    [No Abstract]   [Full Text] [Related]  

  • 22. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.
    Passage E; Norreel JC; Noack-Fraissignes P; Sanguedolce V; Pizant J; Thirion X; Robaglia-Schlupp A; Pellissier JF; Fontés M
    Nat Med; 2004 Apr; 10(4):396-401. PubMed ID: 15034573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A)8-10 April 2005, Naarden, The Netherlands.
    Reilly MM; de Jonghe P; Pareyson D
    Neuromuscul Disord; 2006 Jun; 16(6):396-402. PubMed ID: 16684603
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality of life in children with CMT type 1A.
    Ramchandren S; Shy ME; Finkel RS
    Lancet Neurol; 2009 Oct; 8(10):880-1; author reply 881. PubMed ID: 19747650
    [No Abstract]   [Full Text] [Related]  

  • 25. Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.
    Haberlová J; Seeman P
    Pediatr Neurol; 2010 Dec; 43(6):407-10. PubMed ID: 21093731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.
    Sheth S; Francies K; Siskind CE; Feely SM; Lewis RA; Shy ME
    J Peripher Nerv Syst; 2008 Dec; 13(4):299-304. PubMed ID: 19192070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended treatment of childhood Charcot-Marie-Tooth disease with high-dose ascorbic acid.
    Burns J; Ouvrier RA; Yiu EM; Ryan MM
    J Peripher Nerv Syst; 2011 Sep; 16(3):272-4. PubMed ID: 22003943
    [No Abstract]   [Full Text] [Related]  

  • 28. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy.
    Meyer zu Horste G; Prukop T; Liebetanz D; Mobius W; Nave KA; Sereda MW
    Ann Neurol; 2007 Jan; 61(1):61-72. PubMed ID: 17262851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Charcot-Marie-Tooth disease].
    Lee YC; Chang MH; Lin KP
    Acta Neurol Taiwan; 2008 Sep; 17(3):203-13. PubMed ID: 18975529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study.
    Petersen EE; Magnani P
    Eur J Obstet Gynecol Reprod Biol; 2004 Nov; 117(1):70-5. PubMed ID: 15474248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
    Roa BB; Garcia CA; Lupski JR
    Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.
    Almodovar JL; Ferguson M; McDermott MP; Lewis RA; Shy ME; Herrmann DN
    J Peripher Nerv Syst; 2011 Sep; 16(3):169-74. PubMed ID: 22003930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability and validity of the CMT neuropathy score as a measure of disability.
    Shy ME; Blake J; Krajewski K; Fuerst DR; Laura M; Hahn AF; Li J; Lewis RA; Reilly M
    Neurology; 2005 Apr; 64(7):1209-14. PubMed ID: 15824348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study.
    Lu Q; Björkhem I; Wretlind B; Diczfalusy U; Henriksson P; Freyschuss A
    Clin Sci (Lond); 2005 Jun; 108(6):507-13. PubMed ID: 15675894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary motor and sensory neuropathies or Charcot-Marie-Tooth diseases: an update.
    Tazir M; Hamadouche T; Nouioua S; Mathis S; Vallat JM
    J Neurol Sci; 2014 Dec; 347(1-2):14-22. PubMed ID: 25454638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.